Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.44B | 18.30B | 17.32B | 13.76B | 10.61B |
Gross Profit | ||||
7.28B | 6.73B | 6.22B | 5.16B | 3.73B |
EBIT | ||||
2.13B | 2.34B | 2.09B | 1.77B | 813.00M |
EBITDA | ||||
3.27B | 2.88B | 2.94B | 2.32B | 1.54B |
Net Income Common Stockholders | ||||
1.42B | 1.67B | 1.51B | 982.00M | 498.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.71B | 1.99B | 1.64B | 1.47B | 1.52B |
Total Assets | ||||
31.10B | 29.25B | 29.31B | 29.09B | 19.24B |
Total Debt | ||||
11.33B | 11.40B | 11.91B | 13.14B | 7.19B |
Net Debt | ||||
9.77B | 9.98B | 10.52B | 11.73B | 5.66B |
Total Liabilities | ||||
22.11B | 21.28B | 21.87B | 21.88B | 13.21B |
Stockholders Equity | ||||
8.49B | 7.98B | 7.45B | 7.03B | 6.03B |
Cash Flow | Free Cash Flow | |||
2.27B | 2.13B | 2.33B | 1.77B | 1.08B |
Operating Cash Flow | ||||
3.06B | 2.81B | 2.93B | 2.12B | 1.49B |
Investing Cash Flow | ||||
-1.96B | -937.00M | -645.00M | -5.61B | -370.00M |
Financing Cash Flow | ||||
-973.00M | -1.82B | -2.28B | 3.29B | 100.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $308.57B | 28.70 | 40.98% | 2.73% | 1.15% | 0.28% | |
79 Outperform | $40.81B | 26.56 | 17.43% | 2.39% | 11.73% | -15.34% | |
76 Outperform | $61.43B | 41.66 | 20.00% | ― | 1.47% | -4.87% | |
75 Outperform | $178.40B | 19.13 | 50.06% | 4.16% | -0.38% | 2.23% | |
73 Outperform | $44.83B | 29.90 | 6.13% | 2.69% | 3.95% | -28.73% | |
69 Neutral | $9.85B | 19.65 | 36.83% | 0.70% | 3.21% | 31.83% | |
64 Neutral | $8.78B | 14.55 | 4.78% | 173.91% | 3.39% | 2.17% |